Development of Mechanistic In Vitro-In Vivo Extrapolation to Support Bioequivalence Assessment of Long-Acting Injectables
Long-acting injectable (LAI) formulations provide sustained drug release over an extended period ranging from weeks to several months to improve efficacy, safety, and compliance. Nevertheless, many challenges arise in the development and regulatory assessment of LAI drug products due to a limited un...
Saved in:
Main Authors: | Daniela Amaral Silva (Author), Maxime Le Merdy (Author), Khondoker Dedarul Alam (Author), Yan Wang (Author), Quanying Bao (Author), Nilesh Malavia (Author), Diane Burgess (Author), Viera Lukacova (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Ocular Exposure Extrapolation for a Complex Ophthalmic Suspension Using Physiologically Based Pharmacokinetic Modeling and Simulation
by: Maxime Le Merdy, et al.
Published: (2024) -
Mechanistic modeling of ophthalmic, nasal, injectable, and implant generic drug products: A workshop summary report
by: Ming‐Liang Tan, et al.
Published: (2023) -
Influence of Different Populations on Pharmacokinetic Bioequivalence Results: Can We Extrapolate Bioequivalence Results from One Population to Another?
by: Deniz Ozdin, et al.
Published: (2020) -
PBPK Modeling Approach to Predict the Behavior of Drugs Cleared by Metabolism in Pregnant Subjects and Fetuses
by: Maxime Le Merdy, et al.
Published: (2024) -
Need for Bioequivalence Standards that Reflect the Clinical Importance of the Complex Pharmacokinetics of Paliperidone Palmitate Long-Acting Injectable Suspension
by: Ric M Procyshyn, et al.
Published: (2020)